T cell proliferation and activation

T cell proliferation and activation is a fundamental biological process of the adaptive immune system, characterized by the rapid expansion and functional maturation of T lymphocytes in response to specific antigens. This process is initiated by the interaction of the T cell receptor (TCR) with peptide-MHC complexes on antigen-presenting cells, which triggers intracellular signaling cascades involving calcineurin and the transcription factor NFAT (StatPearls: T Cell Activation). Full activation typically requires secondary costimulatory signals, such as the interaction between CD28 on T cells and B7 molecules on APCs, while inhibitory signals like PD-1 and CTLA-4 serve to terminate the response (NIH/NCI). Once activated, T cells undergo robust clonal expansion primarily driven by the autocrine and paracrine effects of Interleukin-2 (IL-2) (PubMed: 10.1146/annurev.immunol.21.120601.141032). In clinical practice, this process is a major focus for therapeutic intervention; immunosuppressants like calcineurin inhibitors are used to prevent organ transplant rejection and treat autoimmunity, whereas immune checkpoint inhibitors are used in oncology to reinvigorate T cell responses against tumors. Because "T cell proliferation and activation" describes a multi-step physiological pathway and cellular phenotype involving numerous distinct proteins rather than a single molecular entity, it is classified as a biological process rather than a discrete therapeutic target molecule.

Other names

T-cell activationT-cell expansionLymphocyte activationT-cell mediated immune response

Modulation of the T cell receptor (TCR) signaling complex, costimulatory pathways (e.g., CD28/CTLA-4), and cytokine-driven expansion (e.g., IL-2 signaling) to either suppress or enhance immune effector functions (StatPearls, 2023; PubMed: 10.1146/annurev.immunol.21.120601.141032).